- Home
- / Viemed Healthcare
- / Financials
Header placeholder lorem ipsum dolor sit amet, consectetur adipiscing elit.
Viemed Healthcare financials data including stock price, CreditSafe score, income statement, balance sheet, and cash flow.
Stock Price
$9.1
2024-10-29
Market Capitalization
$351.4 M
2024-10-29
Revenue
$270.3 M
FY, 2025
CreditSafe Score
?
Score changed on Jun 10, 2026
Premium Content only available in Craft’s Intelligence Portal
View 30+ financial ratio metrics including price-to-earnings ratio, debt-to-assets ratio, gross profit margin, and more.
Financial ratio metrics help evaluate the financial strength of a company, and help raise red flags that can indicate potential risk, fulfillment challenges, or even possible bankruptcy.
Learn moreFinancial Statements
| USD | FY, 2019 | FY, 2020 | FY, 2021 | FY, 2022 | FY, 2023 | FY, 2024 | FY, 2025 |
|---|---|---|---|---|---|---|---|
| Revenue | 80.3M | 131.3M | 117.1M | 138.8M | 183.0M | 224.3M | 270.3M |
| Cost of goods sold | 24.3M | 51.2M | 43.7M | 54.2M | 70.2M | 91.1M | 114.8M |
| Gross profit | 56.0M | 80.1M | 73.4M | 84.7M | 112.8M | 133.2M | 155.5M |
| Gross profit margin, % | 61.0% | 59.4% | 57.5% | ||||
| General and administrative expense | 41.4M | 52.8M | 54.9M | 68.2M | 87.9M | 106.2M | 121.4M |
| Operating expense total | 47.3M | 53.3M | 61.8M | 76.4M | 98.5M | 115.3M | 132.5M |
| Depreciation and amortization | 671.0K | 816.0K | 851.0K | 1.0M | 1.5M | ||
| EBIT | 8.7M | 26.8M | 11.6M | 8.3M | 14.3M | 17.9M | 22.9M |
| EBIT margin, % | 5.9% | 8.0% | 8.5% | ||||
| Investment income | 935.0K | 485.0K | (954.0K) | ||||
| Interest expense | 197.0K | 424.0K | 776.0K | 1.2M | |||
| Pre tax profit | 8.8M | 26.4M | 12.5M | 9.0M | 14.4M | 16.2M | 21.8M |
| Income tax expense | 271.0K | (5.2M) | 3.4M | 2.8M | 4.1M | 4.8M | 6.4M |
| Net Income | 8.5M | 31.5M | 9.1M | 6.2M | 10.2M | 11.4M | 15.4M |
| EPS | 0.2 | 0.3 | 0.4 |